Pyrotinib in Women With High-risk in Early Stage Breast Cancer
Clinical trial NCT05834764 · RECRUITING
Trial details
- NCT number
- NCT05834764
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-08
- Primary completion
- 2026-06-01
- Enrollment
- 188
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.